Related Experiment Video

Updated: Jul 5, 2026

Robotic Duodenal Sleeve Resection for Gastrointestinal Stromal Tumor with Rare Exon 8 KIT Mutation Following Neoadjuvant Imatinib
06:43

Robotic Duodenal Sleeve Resection for Gastrointestinal Stromal Tumor with Rare Exon 8 KIT Mutation Following Neoadjuvant Imatinib

Published on: April 3, 2026

Adjuvant and down-staging treatment with imatinib in gastrointestinal stromal tumors

B Nilsson, A Andersson, H Ahlman

    Journal of Surgical Oncology
    |May 3, 2008
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Molecular and Immunologic Techniques in a Genetically Engineered Mouse Model of Gastrointestinal Stromal Tumor
    07:21

    Molecular and Immunologic Techniques in a Genetically Engineered Mouse Model of Gastrointestinal Stromal Tumor

    Published on: May 2, 2022

    Related Experiment Videos

    Last Updated: Jul 5, 2026

    Robotic Duodenal Sleeve Resection for Gastrointestinal Stromal Tumor with Rare Exon 8 KIT Mutation Following Neoadjuvant Imatinib
    06:43

    Robotic Duodenal Sleeve Resection for Gastrointestinal Stromal Tumor with Rare Exon 8 KIT Mutation Following Neoadjuvant Imatinib

    Published on: April 3, 2026

    Molecular and Immunologic Techniques in a Genetically Engineered Mouse Model of Gastrointestinal Stromal Tumor
    07:21

    Molecular and Immunologic Techniques in a Genetically Engineered Mouse Model of Gastrointestinal Stromal Tumor

    Published on: May 2, 2022

    Related Concept Videos

    Drugs that Stabilize Microtubules01:15

    Drugs that Stabilize Microtubules

    Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
    Treatment Resistent Cancers02:56

    Treatment Resistent Cancers

    Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

    Articles linked to this work by shared authors, journal, and citation graph.

    Variation of the steroid profile in relation to training in women and its importance for anti-doping testing.

    Frontiers in physiology·2026

    Bending Magnet Synchrotron Radiation Imaging with Large Orbital Collection Angles.

    Physical review letters·2023

    Dose-dependent relationship between nocturnal gastroesophageal reflux and chronic rhinosinusitis in a middle-aged population: results from the SCAPIS pilot.

    Rhinology·2023

    Modeling vitamin B1 transfer to consumers in the aquatic food web.

    Scientific reports·2019

    Source apportionment of circum-Arctic atmospheric black carbon from isotopes and modeling.

    Science advances·2019

    ERα expression in T lymphocytes is dispensable for estrogenic effects in bone.

    The Journal of endocrinology·2018

    Breast-Conserving Therapy Versus Mastectomy in Estrogen Receptor-Positive Breast Cancer: A PAM50-Adjusted Survival Analysis.

    Journal of surgical oncology·2026

    Palliative Transverse Blowhole Colostomy to Address Distal Colonic Obstruction in Advanced Peritoneal Malignancies: A Case Series.

    Journal of surgical oncology·2026

    Walking to the Operating Room: A Qualitative Study of Colorectal Cancer Patient Experiences in a Dutch Academic Hospital.

    Journal of surgical oncology·2026

    Impact of Body Mass Index on Surgical Outcomes After Delayed Breast Reconstruction.

    Journal of surgical oncology·2026

    The Epitrochlear and Humeral Lymphatic Pathway: Deep Lymphatic System Compensation After Axillary Lymph Node Dissection.

    Journal of surgical oncology·2026

    Dynamic ctDNA Monitoring Predicts Recurrence and Guides Therapy in Postoperative Hepatocellular Carcinoma.

    Journal of surgical oncology·2026

    Correction: The immunopathogenesis of uveitis.

    Frontiers in medicine·2026

    Effects of Different Exogenous Insulin Analog Treatments on the Evaluation of Pancreatic Islet Function in Diabetes.

    Journal of diabetes research·2026

    Research hotspots and trends in biliary tract cancers immunotherapy are revealed by a bibliometric study spanning the years 2014 to 2024.

    Medicine·2026

    Use of the Combination Therapy of Recombinant Feline Interferon-Omega Injection and Oral Prednisolone for Canine Aural Hematoma: A Retrospective Case Series.

    Veterinary sciences·2026

    Recombinant Antibody Vaccines for Targeted Antigen Delivery: Design Principles and Immunological Applications.

    Vaccines·2026

    How Does Inter-Epitope Spacer Variation Within Artificial Immunogens Based on T-Cell Epitopes of Tick-Borne Encephalitis Virus Affect Immunogenicity?

    Vaccines·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us